Novo Nordisk Inc. Pac (Novo Nordisk Pac) YEAR-END Filings

Cycle Date Filed End Date Amendment Receipts Spending Cash
2024 Jan. 31 Dec. 31, 2023 $136,651.30 $127,000.00 $78,605.10
2022 Jan. 26, 2023 Dec. 31, 2022 $19,319.60 $9,000.00 $97,739.40
2022 Jan. 28, 2022 Dec. 31, 2021 $118,076.50 $155,500.00 $59,078.40
2020 Jan. 22, 2021 Dec. 31, 2020 $29,687.90 $37,500.00 $65,036.20
2020 Jan. 23, 2020 Dec. 31, 2019 $20,045.30 $58,000.00 $79,894.08
2018 Jan. 17, 2019 Dec. 31, 2018 $32,496.50 $0.00 $54,461.54
2018 Jan. 24, 2018 Dec. 31, 2017 $31,368.50 $45,000.00 $16,856.96
2016 Jan. 18, 2017 Dec. 31, 2016 $35,002.50 -$3,500.00 $128,092.96
2016 March 16, 2016 Dec. 31, 2015 Compare to original $25,329.00 $38,000.00 $192,394.02
2016 Jan. 28, 2015 Dec. 31, 2014 $25,598.00 $2,500.00 $69,673.35
2014 May 14, 2014 Dec. 31, 2013 Compare to original $20,623.00 $33,551.40 $77,172.61
2012 March 20, 2013 Dec. 31, 2012 Compare to original $13,315.00 $11,185.72 $17,193.28
2012 Jan. 26, 2012 Dec. 31, 2011 $10,602.00 $13,615.38 $29,043.73
2010 Jan. 26, 2011 Dec. 31, 2010 $11,764.00 $2,531.02 $21,633.20
2010 Jan. 28, 2010 Dec. 31, 2009 $7,101.00 $16,798.24 $12,335.01
2008 Jan. 29, 2009 Dec. 31, 2008 $10,333.00 -$970.00 $18,604.40
2008 March 19, 2008 Dec. 31, 2007 Compare to original $22,170.00 $26,818.90 $5,097.50
2006 Jan. 31, 2007 Dec. 31, 2006 View View